Bismuth therapy in gastrointestinal diseases

Sherwood L. Gorbach(Tufts University)

Gastroenterology

September 1, 1990

10.1016/0016-5085(90)90983-8

Cited by 233

Abstract

Related Papers

Attempt to fulfil Koch's postulates for pyloric Campylobacter

Barry J. Marshall, John A. Armstrong, David B. McGechie et al.|The Medical Journal of Australia|1985|1.3k

Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment.

Erik A.J. Rauws, W. Langenberg, H. J. Houthoff et al.|PubMed|1988|773

The Clinical Significance of <i>Campylobacter pylori</i>

Cornelius P. Dooley, HARTLEY COHEN|Annals of Internal Medicine|1988|265

Fecal Blood Loss Produced by Oral and Intravenous Administration of Various Salicylates

Morton I. Grossman, Kenneth K. Matsumoto, Raymond J. Lichter|Gastroenterology|1961|212

Symptomatic Treatment of Diarrhea With Bismuth Subsalicylate Among Students Attending a Mexican University

Herbert L. DuPont, Peggy Sullivan, Larry K. Pickering et al.|Gastroenterology|1977|185